Clinical Trial Update: Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results evaluating ALXN1840 for Wilson disease, including copper concentration and liver histopathologic changes; results posted 2023-07-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• ALXN1840 (ALXN1840)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Wilson Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-07-03